| Literature DB >> 3005203 |
M Seiki, J Inoue, T Takeda, A Hikikoshi, M Sato, M Yoshida.
Abstract
Human T-cell leukemia virus type I has a unique sequence pX and the product p40x was proposed to be a specific trans-acting transcriptional activator of expression of the viral gene. Recently, a second pX protein p27x-III in addition to p40x was identified; these two proteins are encoded by overlapping frames III and IV (x-lor). For determination of which product is the trans-acting activator, site-directed mutations were introduced into the pX sequence which was placed under the metallothionein promoter. On cotransfection with pLTR-CAT (a plasmid containing the LTR of HTLV-I and chloramphenicol acetyltransferase gene), only the mutations that affected p40x expression inactivated the transcriptional activation from the LTR.Entities:
Mesh:
Substances:
Year: 1985 PMID: 3005203
Source DB: PubMed Journal: Jpn J Cancer Res ISSN: 0910-5050